Observational studyInternational journal of immunopathology and pharmacology

Efficacy and safety of human intravenous immunoglobulin 5% (Ig VENA) in pediatric patients affected by primary immunodeficiency.

Silvia Ricci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.